SURGICALLY TARGETED RADIATION THERAPY FOR PATIENTS WITH OPERABLE BRAIN TUMORS
Note: In January 2020, GammaTile Therapy was FDA cleared for the treatment of newly diagnosed malignant brain tumors of all types in addition to the existing clearance for recurrent brain tumors.
Physician Perspective | March 18, 2020 | Dr David McCracken, neurosurgeon at Piedmont Healthcare
North Carolina CBS | January 24, 2020 | Vidant Health™ and ECU Brody School of Medicine successfully perform first-in-state GammaTile procedure
Ohio CBS | November 15, 2019 | New brain cancer therapy provides radiation right at tumor site
Cronkite News, Arizona PBS | October 22, 2019 | Battling brain tumors with time-released radiation
Ohio CBS | August 20, 2019 | Mayfield Brain and Spine neurosurgeon using new radiation therapy
Arizona CBS | August 14, 2019 | New therapy to slow down brain tumors forever changes Arizona woman's life
Arizona PBS | June 11, 2019 | Implantable brain tumor treatment GammaTile Therapy with Dr David Brachman
Minnesota CBS | February 14, 2019 | New brain cancer treatment GammaTile Therapy at University of Minnesota with survivor Linda Tinega
Physician Perspective | August 14, 2019 | Dr Clark Chen, neurosurgeon at University of Minnesota Health
Introducing GammaTile Therapy
Clinical Presentation | May 1, 2020 | GammaTile Therapy clinical case review with Dr Vincent DiNapoli
Glioma Case Example I
Brain Metastases Case Example
GammaTile Therapy is indicated to deliver radiation therapy for patients with newly diagnosed malignant intracranial neoplasms and recurrent intracranial neoplasms.
For full safety information, refer to the GammaTile Instructions for Use.
Glioma Case Example II
Meningioma Case Example